Changes in the pharmacokinetics of lurasidone in a pregnant woman with schizophrenia
Abstract Background The population of pregnant women with schizophrenia is increasing. Managing schizophrenia during pregnancy poses unique challenges due to the potential effects of second‐generation antipsychotics on maternal mental health and fetal development and changes in drug pharmacokinetics...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | PCN Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/pcn5.70043 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|